Sept. 13 (Bloomberg) -- Bristol-Myers Squibb Co., the maker of the most prescribed diabetes pill, is developing three new drugs to target the world's fastest growing disease, each of which carries a $1 billion-a-year sales potential.
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment